Immunai was founded in December 2018. We are a multidisciplinary team of immunologists, genomics technologists, computer scientists, engineers, mathematicians and operators singularly focused on solving an audacious challenge. Backed by some of the leading scientific minds in immunology, oncology, and single cell genomics, we are up for the challenge.
Our team spans New York City, Tel Aviv and San Francisco.
We are excited to explore strategic partnerships with academic research institutions, biopharmaceutical companies, and biotechs to expand the use of our technology and data platform to unlock biological insights, advance novel therapeutic discovery, and accelerate R&D.Contact Us